Literature DB >> 21161400

Association of ADAM33 gene with susceptibility to COPD in Tibetan population of China.

Jinling Xiao1, Jianyu Han, Xinyan Wang, Demi Hua, Dongju Su, Yongxia Bao, Fuzhen Lv.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a common, complex disorder associated with substantial morbidity and mortality, influenced by both environmental factor and genetic factor. ADAM33 gene was found to be associated with asthma, declined lung function and COPD. The purpose of the study was to test whether SNPs in ADAM33 were associated with COPD in Tibetan population of China. Polymerase chain reaction-restriction fragment length polymorphism was carried out to genotype the eight SNPs (V4, T2, T1, S2, S1, Q-1 and F + 1) of ADAM33 on 240 COPD patients and 221 healthy individuals. Four SNPs (V4, T2, T1 and S1) and four haplotypes (H2 CGAAGAGC, H5 GAGAGAGC, H9 GAAAGAGC and H6 CGGGGAGC of ADAM33 gene were associated with COPD significantly (defined as P < 0.05). The results indicate that there is an association between ADAM33 polymorphisms and COPD in Tibetan population of China.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21161400     DOI: 10.1007/s11033-010-0637-6

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  16 in total

1.  Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma.

Authors:  H Jongepier; H M Boezen; A Dijkstra; T D Howard; J M Vonk; G H Koppelman; S L Zheng; D A Meyers; E R Bleecker; D S Postma
Journal:  Clin Exp Allergy       Date:  2004-05       Impact factor: 5.018

2.  The natural history of chronic airflow obstruction.

Authors:  C Fletcher; R Peto
Journal:  Br Med J       Date:  1977-06-25

3.  ADAM33 haplotypes are associated with asthma in a large Australian population.

Authors:  Mary-Anne Kedda; David L Duffy; Bernadette Bradley; Robyn E O'Hehir; Philip J Thompson
Journal:  Eur J Hum Genet       Date:  2006-06-14       Impact factor: 4.246

4.  A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology.

Authors:  Margot M E Gosman; H Marike Boezen; Cleo C van Diemen; Jiska B Snoeck-Stroband; Thérèse S Lapperre; Pieter S Hiemstra; Nick H T Ten Hacken; Jan Stolk; Dirkje S Postma
Journal:  Thorax       Date:  2006-11-07       Impact factor: 9.139

5.  ADAM33 polymorphisms are associated with asthma susceptibility in a Japanese population.

Authors:  E Noguchi; Y Ohtsuki; K Tokunaga; M Yamaoka-Sageshima; K Ichikawa; T Aoki; M Shibasaki; T Arinami
Journal:  Clin Exp Allergy       Date:  2006-05       Impact factor: 5.018

6.  Developing COPD: a 25 year follow up study of the general population.

Authors:  A Løkke; P Lange; H Scharling; P Fabricius; J Vestbo
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

7.  The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group.

Authors:  D P Tashkin; M D Altose; E R Bleecker; J E Connett; R E Kanner; W W Lee; R Wise
Journal:  Am Rev Respir Dis       Date:  1992-02

8.  Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness.

Authors:  Paul Van Eerdewegh; Randall D Little; Josée Dupuis; Richard G Del Mastro; Kathy Falls; Jason Simon; Dana Torrey; Sunil Pandit; Joyce McKenny; Karen Braunschweiger; Alison Walsh; Ziying Liu; Brooke Hayward; Colleen Folz; Susan P Manning; Alicia Bawa; Lisa Saracino; Michelle Thackston; Youssef Benchekroun; Neva Capparell; Mei Wang; Ron Adair; Yun Feng; JoAnn Dubois; Michael G FitzGerald; Hui Huang; René Gibson; Kristina M Allen; Alex Pedan; Melvyn R Danzig; Shelby P Umland; Robert W Egan; Francis M Cuss; Steuart Rorke; Joanne B Clough; John W Holloway; Stephen T Holgate; Tim P Keith
Journal:  Nature       Date:  2002-07-10       Impact factor: 49.962

9.  Association of ADAM33 gene polymorphisms with COPD in a northeastern Chinese population.

Authors:  Xinyan Wang; Lei Li; Jinling Xiao; Chengzhen Jin; Kun Huang; Xiaowen Kang; Xiaomei Wu; Fuzhen Lv
Journal:  BMC Med Genet       Date:  2009-12-10       Impact factor: 2.103

10.  Adam33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers.

Authors:  Alireza Sadeghnejad; Jill A Ohar; Siqun L Zheng; David A Sterling; Gregory A Hawkins; Deborah A Meyers; Eugene R Bleecker
Journal:  Respir Res       Date:  2009-03-12
View more
  7 in total

1.  Association of SERPINE2 gene with the risk of chronic obstructive pulmonary disease and spirometric phenotypes in northern Han Chinese population.

Authors:  Li An; Ting Yang; Yongbiao Zhang; Yingxiang Lin; Hong Zhang; Xia Jiao; Lin Hua; Huaping Dai; Chen Wang
Journal:  Mol Biol Rep       Date:  2011-05-25       Impact factor: 2.316

2.  Regulation of a disintegrin and metalloprotease-33 expression by transforming growth factor-β.

Authors:  Youwen Yang; James Wicks; Hans Michael Haitchi; Robert M Powell; Wiparat Manuyakorn; Peter H Howarth; Stephen T Holgate; Donna E Davies
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01-06       Impact factor: 6.914

3.  TGF-β1 stimulates epithelial-mesenchymal transition mediated by ADAM33.

Authors:  Liping Fang; Jie Wu; Tao Huang; Pengpeng Zhang; Xiaofeng Xin; Yi Shi
Journal:  Exp Ther Med       Date:  2017-11-10       Impact factor: 2.447

4.  Association of a disintegrin and metalloprotease 33 (ADAM33) gene polymorphisms with the risk of COPD: an updated meta-analysis of 2,644 cases and 4,804 controls.

Authors:  Deng-Chuan Zhou; Cheng-Fan Zhou; Sam Toloo; Tong Shen; Shi-Lu Tong; Qi-Xing Zhu
Journal:  Mol Biol Rep       Date:  2014-10-04       Impact factor: 2.316

5.  A disintegrin and metalloprotease 33 polymorphism association with COPD in long-term tobacco smokers of the ethnic Kashmiri population of India.

Authors:  Sonaullah Shah; Amir Rashid; Zaffar A Shah; Rafi Ahmad Jan; Umar Hafiz Khan; Imtiyaz A Bhat; Suhail Mantoo; Tajamul H Shah; Parvaiz A Koul
Journal:  Lung India       Date:  2015 May-Jun

6.  Gene polymorphisms and chronic obstructive pulmonary disease.

Authors:  Xiaodan Wu; Bowei Yuan; Elena López; Chunxue Bai; Xiangdong Wang
Journal:  J Cell Mol Med       Date:  2013-11-21       Impact factor: 5.310

Review 7.  Genetic polymorphism and chronic obstructive pulmonary disease.

Authors:  Cunhua Yuan; Guangming Lu; Xiaowei Deng
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-05-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.